Life Sciences and Medical Device Translation Services
Life Sciences Translation Services for Regulated Global Healthcare Markets
AsiaLocalize provides life sciences translation services for pharmaceutical, biotech, CRO and medical device companies entering Asian and global markets. Medical and scientific linguists translate regulatory submissions, clinical trial documents, labeling, IFUs and patient materials in 120+ languages, with terminology control, TEP review, back translation and secure handling of sensitive files.
- ISO 17100 & ISO 13485 certified
- Life sciences subject-matter experts
- Confidential handling: files shared only with your project’s linguists
- APAC market expertise across Asian languages
- Support for clinical, regulatory, technical, and patient-facing content
Quick definition
What Is Life Sciences Translation?
Life sciences translation is the specialized translation of pharmaceutical, biotechnology, clinical research, medical device and regulatory content, where accuracy affects submission readiness, patient safety and market access. AsiaLocalize translates IFUs, labeling, clinical trial documents and regulatory submissions for EU MDR, FDA and Asian markets such as China (NMPA), Japan (PMDA), South Korea (MFDS) and India (CDSCO), with back translation for high-risk content.
Life sciences translation at a glance
- Sectors: pharma, biotech, CROs, medical devices and healthcare.
- Documents: regulatory submissions, clinical trial, labeling, IFUs and patient materials.
- Linguists: translators and reviewers with medical and scientific experience.
- Quality: TEP workflow, terminology management and back translation.
- Markets: APAC and global markets in 120+ languages.
See also: clinical trials translation, pharmaceutical translation and medical translation.
Published: · Last reviewed:
Challenges
What Translation Challenges Can Delay Life Sciences Market Access?
In life sciences, translation mistakes can delay submissions, weaken regulatory confidence, affect patient understanding and increase compliance risk.
Regulatory Complexity
Terminology, formatting, structure and approved wording must stay consistent across APAC and global regulators.
Specialized Subject Matter
Clinical, pharma, biotech and device content needs translators who understand scientific and regulatory language.
Speed Without Accuracy Loss
Submissions, trials and launches move fast; content must be delivered quickly without compromising review or confidentiality.
Our solutions
Which Life Sciences Sectors Do We Translate For?
Support across the full lifecycle, from research and clinical development to approval, manufacturing, commercialization and post-market communication.
Pharmaceutical
Regulatory submissions, pharmacovigilance, CMC, labels, package inserts and SOPs.
Explore →
Biotechnology
Lab protocols, patents, genetic research, publications and technical reports.
Explore →
Clinical Research
Protocols, ICFs, CRFs, investigator brochures, ethics submissions and CSRs.
Explore →
Medical Devices
IFUs, manuals, clinical evaluation reports, risk files, labeling and software UI.
Explore →
Regulatory
CTD/eCTD files, MAAs, GMP/GCP documentation, audit responses and registrations.
Documents
Which Life Sciences Documents Do We Translate?
Regulatory and Submission
- CTD and eCTD files
- IND, NDA, MAA and 510(k) documentation
- GMP, GCP and quality system documents
- Product registration files
Clinical Trial
- Protocols and investigator brochures
- Informed consent and case report forms
- Clinical study reports and ethics submissions
- Patient-reported outcome instruments
Pharmaceutical
- Drug labels and package inserts
- Patient information leaflets
- Pharmacovigilance reports
- CMC documentation and SOPs
Medical Device
- Instructions for use and user manuals
- Clinical evaluation and risk management files
- Labeling and packaging
- Software UI and help content
Research and Scientific
- Manuscripts and research papers
- Laboratory protocols
- Preclinical study reports
- Grant applications
Commercial and Patient-Facing
- HCP materials and brochures
- Patient education materials
- Launch and market access content
- Website and digital content
What Do Regulators Require You to Translate in Each Market?
Every regulator sets its own language rules for labels, instructions for use and submissions. This overview shows what typically needs translating in the major markets we support.
| Market | Regulator | What typically needs translating |
|---|---|---|
| European Union | EU MDR (2017/745) and IVDR (2017/746) | Labels and instructions for use in the official language(s) required by each member state where the device is made available |
| United States | FDA | Labeling in English; foreign-language source documents in a submission need an English translation |
| China | NMPA | Registration dossier, labels and instructions for use in Simplified Chinese |
| Japan | PMDA / MHLW | Application documents, labeling and package inserts in Japanese |
| South Korea | MFDS | Application documents, labels and instructions for use in Korean |
| India | CDSCO | Labeling generally in English; check product-specific rules for local-language requirements |
| Southeast Asia | e.g. HSA (Singapore), Thai FDA, Indonesian Ministry of Health | English and/or local-language labeling, depending on the country and product class |
Last reviewed October 2026. Requirements differ by device class, product type and country, and they change. Confirm the current rules with your regulatory team or local representative before submission. For a deeper look at device content, read our guide to medical device translation.
Quality and compliance
How Do We Control Quality in Regulated Life Sciences Translation?
Each project is handled as a controlled documentation workflow, with checks adapted to document type, risk level, language pair and regulatory context.
Terminology Management
Approved glossaries, termbases and translation memories for product names, medical terms and dosage language.
Subject-Matter Review
Linguists with medical, pharmaceutical, biotech, clinical or regulatory experience.
TEP Workflow
Translation, editing and proofreading with checks on meaning, numbers, units, symbols and tables.
Regulatory Formatting
Structure, tables, labels, symbols, numbering and references preserved for submission.
Confidential Handling
Files are shared only with the linguists assigned to your project.
Back Translation and Validation
Back translation and linguistic validation for high-risk content.
Our workflow
How Does Our Life Sciences Translation Workflow Work?
01
Intake and File Review
Source files, document type, languages, regulatory context, format and timeline.
02
Terminology and References
Glossaries, prior translations, style guides and market instructions collected.
03
Specialist Assignment
Linguists matched to pharma, biotech, clinical, device or healthcare content.
04
Translate, Edit, Proofread
Structured TEP for accuracy, terminology, readability and source alignment.
05
QA, Delivery and Support
Final QA, delivery in the required format and maintained translation assets.
Why AsiaLocalize
Why Do Life Sciences Companies Choose AsiaLocalize?
APAC Expertise
Major APAC languages and region-specific communication needs.
Medical and Scientific Linguists
Clinical, pharma, biotech, regulatory, device and healthcare experience.
Scalable Delivery
Urgent files, recurring programs, high-volume batches and launches.
Need-to-Know File Access
Files are shared only with the linguists assigned to your project.
Consistency Across Projects
Translation memories, glossaries and style guides keep content aligned.
Support Beyond Translation
DTP, back translation, linguistic validation and ongoing updates.
What clients say about our work
Expert Insights for Life Sciences
Frequently Asked Questions About Life Sciences Translation
Why can't I use machine translation for life sciences documents?
Machine translation lacks the subject-matter expertise, regulatory knowledge, and precision required for life sciences content. MT struggles with complex terminology, regulatory nuances, and cultural adaptation. While AI tools may provide drafts, human medical translators with scientific backgrounds are essential for accuracy, regulatory compliance, and patient safety in life sciences translation.
How do you ensure regulatory compliance across different markets?
Our translators specialize in regional regulatory requirements (FDA, EMA, PMDA, NMPA, etc.) and stay current with evolving guidelines. We use market-specific style guides, regulatory templates, and compliance checklists. Each translation undergoes regulatory review to verify format adherence, required elements, and jurisdiction-specific terminology before delivery.
What qualifications do your life sciences translators have?
All life sciences translators hold advanced degrees (Master’s or PhD) in relevant scientific fields—pharmacology, biotechnology, medicine, or related disciplines. They possess minimum 5 years of professional translation experience in life sciences, undergo continuous training on regulatory updates, and are native speakers based in target markets for cultural accuracy.
How long does a typical life sciences translation project take?
Timelines vary by project scope and complexity. Standard documents (2,000-5,000 words) typically require 3-5 business days. Large regulatory submissions may need 4-8 weeks for proper translation, review, and QA. We offer expedited services for urgent projects. Contact us with your specific requirements for accurate timeline estimates.
Are clinical trial files kept confidential?
Yes. Files are shared only with the linguists assigned to your project.
What are the EU MDR translation requirements?
Under EU MDR, labels and instructions for use must be provided in the official language or languages required by each member state where the device is made available. The exact requirements depend on the country and device class, so we confirm the target languages for each market before translation starts.
Which Asian regulatory markets do you support?
We translate regulatory, labeling and clinical content for major Asian regulators, including China (NMPA), Japan (PMDA), South Korea (MFDS) and India (CDSCO), as well as Southeast Asian markets, alongside EU and US filings.
Ready to Translate Life Sciences Content for Global and APAC Markets?
Partner with AsiaLocalize for life sciences translation services built around accuracy, regulatory awareness, confidentiality, and scientific precision.
Whether you are preparing regulatory submissions, conducting international clinical trials, launching a medical device, translating pharmaceutical content, or expanding into APAC markets, our team can support your next multilingual project.
